Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study
Objective: To evaluate the effects of once-daily valbenazine (VBZ) on the impacts of tardive dyskinesia (TD) using multiple patient-reported outcomes (PROs), including the psychometrically validated…Hemichorea and Oromandibular Stereotypies Following Immunomodulatory Therapy in Multiple Myeloma: A Case Report
Objective: To describe a unique case of hemichorea and oromandibular stereotypies as a possible side effect of immunotherapy for multiple myeloma. Background: Multiple myeloma is…Scopolamine-induced Tardive Dyskinesia: A Case Report
Objective: To present a case of scopolamine-related Tardive Dyskinesia (TD) and review the documented anticholinergic-associated cases of TD and the underlying pathophysiology responsible for TD.…Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study
Objective: Our goal was to evaluate the feasibility, effectiveness, and acceptability of a remote consultation with a movement disorder neurologist to patients suspected to have…Physical, Mental, and Socioemotional Functional Improvement Following Valbenazine Treatment for TD: a Case Series
Objective: Describe clinical characteristics and changes in mental, socioemotional, and physical domains of individuals with tardive dyskinesia (TD) after valbenazine (VBZ) treatment. Background: Prior research…Exploring the Neuroprotective Potential of Raloxifene and Fulvestrant Against Haloperidol Induced Parkinson Disease; Insights into GPR30/PI3k/Akt/Nrf2 Signaling Pathways
Objective: To investigate the neuroprotective effect of raloxifene and fulvestrant on behavioral, biochemical, neurochemical, and molecular alterations in a haloperidol-induced animal model of Tardive dyskinesia.To…Remission of Tardive Dyskinesia in Patients Receiving Long-Term Valbenazine Treatment
Objective: To assess a potential threshold for remission of tardive dyskinesia (TD) during treatment with once-daily valbenazine, a uniquely selective vesicular monoamine transporter 2 inhibitor.…Real-World Effectiveness of the 4-Week Patient Deutetrabenazine-Titration Kit for Tardive Dyskinesia Across Races: START Study Post Hoc Analysis
Objective: To assess the effectiveness of a 4-week deutetrabenazine (DTBZ) titration kit in patients with tardive dyskinesia (TD), stratified by race. Background: The START study…Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol
Objective: To reproduce the side effects of antipsychotic drugs (drug-induced Parkinsonism and tardive dyskinesia) in rats and elucidate its pathomechanism by examining morphological changes in…GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.
Objective: Objective:1. To investigate the neuroprotective effect of FDA-approved compounds (Raloxifene and Fulvestrant) against haloperidol-induced neurotoxicity in SHSY-5Y cells and adult zebrafish2. To explore the molecular…
- 1
- 2
- 3
- …
- 9
- Next Page »